BR0113634A - Antibióticos de cefalosporina e suas pró-drogas - Google Patents

Antibióticos de cefalosporina e suas pró-drogas

Info

Publication number
BR0113634A
BR0113634A BR0113634-8A BR0113634A BR0113634A BR 0113634 A BR0113634 A BR 0113634A BR 0113634 A BR0113634 A BR 0113634A BR 0113634 A BR0113634 A BR 0113634A
Authority
BR
Brazil
Prior art keywords
prodrugs
antibiotics
cephalosporin antibiotics
cefalosporin
bacteria
Prior art date
Application number
BR0113634-8A
Other languages
English (en)
Inventor
Tomasz W Glinka
Original Assignee
Tomasz W Glinka
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tomasz W Glinka filed Critical Tomasz W Glinka
Publication of BR0113634A publication Critical patent/BR0113634A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Abstract

"ANTIBIóTICOS DE CEFALOSPORINA E SUAS PRó-DROGAS". A presente invenção refere-se a novos antibióticos de cefalosporina, suas pró-drogas e sais farmacologicamente aceitáveis destes, que são ativos contra um amplo espectro de bactérias que são resistentes a antibióticos de beta-lactama clínicos atuais.
BR0113634-8A 2000-08-29 2001-08-23 Antibióticos de cefalosporina e suas pró-drogas BR0113634A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US22917400P 2000-08-29 2000-08-29
PCT/US2001/026628 WO2002017854A2 (en) 2000-08-29 2001-08-23 Cephalosporin antibiotics and prodrugs thereof

Publications (1)

Publication Number Publication Date
BR0113634A true BR0113634A (pt) 2004-02-03

Family

ID=22860110

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0113634-8A BR0113634A (pt) 2000-08-29 2001-08-23 Antibióticos de cefalosporina e suas pró-drogas

Country Status (16)

Country Link
US (1) US6599893B2 (pt)
EP (1) EP1333836A4 (pt)
JP (1) JP2004507481A (pt)
CN (1) CN1471399A (pt)
AR (1) AR030503A1 (pt)
AU (2) AU2001288420B2 (pt)
BR (1) BR0113634A (pt)
CA (1) CA2420871A1 (pt)
IL (1) IL154518A0 (pt)
MX (1) MXPA03001782A (pt)
NO (1) NO20030931L (pt)
NZ (1) NZ524438A (pt)
RU (1) RU2281948C2 (pt)
TW (1) TWI283681B (pt)
WO (1) WO2002017854A2 (pt)
ZA (1) ZA200301391B (pt)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0307834D0 (en) * 2003-04-04 2003-05-14 Ta Contrast Ab Composition
CA2526875A1 (en) * 2003-04-30 2004-11-18 Trine Pharmaceuticals, Inc. Carbacephem beta-lactam antibiotics
CN101210020B (zh) * 2006-12-31 2010-11-24 山东轩竹医药科技有限公司 新型头孢菌素化合物
EA201070504A1 (ru) * 2007-10-25 2010-12-30 Эйкеоджен, Инк. КАРБАЦЕФЕМ β-ЛАКТАМОВЫЕ АНТИБИОТИКИ
EP2285381B1 (en) 2008-05-05 2015-12-16 The General Hospital Corporation Photoactivatable beta-lactamase substrates and analytical methods of using same
CN103945842A (zh) 2011-09-09 2014-07-23 丘比斯特药物股份有限公司 治疗肺内感染的方法
US8809314B1 (en) 2012-09-07 2014-08-19 Cubist Pharmacueticals, Inc. Cephalosporin compound
US8476425B1 (en) 2012-09-27 2013-07-02 Cubist Pharmaceuticals, Inc. Tazobactam arginine compositions
US20140274991A1 (en) 2013-03-15 2014-09-18 Cubist Pharmaceuticals, Inc. Ceftolozane pharmaceutical compositions
KR102329764B1 (ko) 2013-03-15 2021-11-23 머크 샤프 앤드 돔 코포레이션 세프톨로잔 항균성 조성물
US9872906B2 (en) 2013-03-15 2018-01-23 Merck Sharp & Dohme Corp. Ceftolozane antibiotic compositions
CA2910752C (en) * 2013-05-01 2021-11-23 Neoculi Pty Ltd Use of robenidine in the treatment of bacterial infection
WO2015035376A2 (en) 2013-09-09 2015-03-12 Calixa Therapeutics, Inc. Treating infections with ceftolozane/tazobactam in subjects having impaired renal function
US20150094293A1 (en) 2013-09-27 2015-04-02 Calixa Therapeutics, Inc. Solid forms of ceftolozane
AR110451A1 (es) * 2016-12-26 2019-03-27 Shionogi & Co Compuesto tricíclico que tiene sulfinilo y composición farmacéutica que lo comprende

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0009008A3 (de) * 1978-09-08 1980-05-14 Ciba-Geigy Ag Cephalosporinderivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Präparate
TW427993B (en) * 1993-09-09 2001-04-01 Fujisawa Pharmaceutical Co New cephem compounds
JPH10510258A (ja) * 1994-12-09 1998-10-06 藤沢薬品工業株式会社 セフェム化合物およびその医薬用途
MY127641A (en) * 1995-10-12 2006-12-29 Essential Therapeutics Inc Cephalosporin antibiotics
JPH09278778A (ja) * 1996-04-12 1997-10-28 Kyorin Pharmaceut Co Ltd 抗ｍｒｓａセファロスポリン化合物
US6030965A (en) * 1997-09-30 2000-02-29 Microcide Pharmaceuticals, Inc. Cephalosporin antibiotics

Also Published As

Publication number Publication date
WO2002017854A2 (en) 2002-03-07
CN1471399A (zh) 2004-01-28
ZA200301391B (en) 2004-02-20
TWI283681B (en) 2007-07-11
JP2004507481A (ja) 2004-03-11
US6599893B2 (en) 2003-07-29
CA2420871A1 (en) 2002-03-07
EP1333836A4 (en) 2004-07-07
AU2001288420B2 (en) 2006-09-28
IL154518A0 (en) 2003-09-17
MXPA03001782A (es) 2004-11-01
AR030503A1 (es) 2003-08-20
NO20030931D0 (no) 2003-02-27
US20020115650A1 (en) 2002-08-22
NO20030931L (no) 2003-04-29
NZ524438A (en) 2005-08-26
WO2002017854A3 (en) 2002-06-13
EP1333836A2 (en) 2003-08-13
RU2281948C2 (ru) 2006-08-20
AU8842001A (en) 2002-03-13

Similar Documents

Publication Publication Date Title
BR0113634A (pt) Antibióticos de cefalosporina e suas pró-drogas
EP0984947B8 (en) Oxazolidinone antibacterial agents having a thiocarbonyl functionality
BR0213063A (pt) Antibióticos de ação dupla
HN1999000045A (es) Derivados biciclicos del acido hidroxamico
RS50091B (sr) Upotreba retigabina u lečenju neuropatskog bola
BR0109836A (pt) Processo de sìntese de perindopril e de seus sais farmaceuticamente aceitáveis
EE200100487A (et) Uudsed ühendid ja kompositsioonid proteaasiinhibiitoritena
BR9916798A (pt) 4-arilamino, 4-arilóxi e 4-ariltio diarilaminas e seus derivados como inibidores seletivos de mek
PT960107E (pt) Compostos de paclitaxel 6-tio-substituidos
DK0920421T3 (da) Isoxazolinderivater anvendelige som antimikrobielle midler
BR0300709A (pt) Sal de perindopril e as composições farmacêuticas contendo o mesmo
AP2003002942A0 (en) New derivatives of oxazolidinones as bacterial agents
BR0315139A (pt) Agentes antibacterianos de tetraidroquinolina tricìclica
SE9901077D0 (sv) Novel use
RS20050649A (en) Antibacterial indolone oxazolidinones,intermediates for their preparation and pharmaceutical compositions containing them
SE9801494D0 (sv) Novel use
BR0104358A (pt) Formulações de taxana tendo solubilidade aperfeiçoada
AR029544A1 (es) Composiciones y metodos para tratar infecciones bacterianas
MXPA03008837A (es) Una composicion farmaceutica estable de pravastatina.
PT1411956E (pt) Utilizacao de polissacaridos sobre-sulfatados como inibidores de vih
AU2003259159A1 (en) N-aryl-2-oxazolidinones and their derivatives
BRPI0413744A (pt) n-aril-2-ciano-oxazolidinonas e seus derivados
PT1011329E (pt) Paclitaxeis de 7-metiltio-oxometilo e 7-metiltiodioxometilo
BR0014230A (pt) Antibióticos de ácido 7-acilamino-3-heteroariltio-3-cefem carboxìlico e suas pró-drogas
ES2179668T3 (es) Un compuesto wf002, su produccion y su uso.

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 7A E 8A ANUIDADES

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2021 DE 29/09/2009.